Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data
- 1 July 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 12 (7), 650-658
- https://doi.org/10.1016/s1474-4422(13)70104-2
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The natural history of spinocerebellar ataxia type 1, 2, 3, and 6 A 2-year follow-up studyNeurology, 2011
- Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyondThe Lancet Neurology, 2010
- Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based studyBrain, 2009
- Spinocerebellar ataxia types 1, 2, 3, and 6Neurology, 2008
- Age at onset variance analysis in spinocerebellar ataxias: A study in a Dutch–French cohortAnnals of Neurology, 2005
- Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesisThe Lancet Neurology, 2004
- Spinocerebellar ataxias in the NetherlandsNeurology, 2002
- Spinocerebellar ataxia 3 and machado‐joseph disease: Clinical, molecular, and neuropathological featuresAnnals of Neurology, 1996
- Analysis of the SCAI CAG repeat in a large number of families with dominant ataxia: Clinical and molecular correlationsAnnals of Neurology, 1995
- Autosomal dominant cerebellar ataxiaNeurology, 1990